IP Library Patent Application 11851944
Patent Application
App. No. 11/851,944

Wound Irrigation Device

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/851,944
Abstract

An apparatus includes a fluid permeable dressing and a cover membrane configured to extend over the fluid permeable dressing. A tube is coupled to the fluid permeable dressing and is configured to apply suction through the fluid permeable dressing. A fluid reservoir is coupled to the cover membrane, the fluid vessel including an inlet port configured to receive a fluid and an outlet port fluidically coupled to the fluid permeable dressing.

Claims (32)

1 . An apparatus, comprising:

a porous substrate;

a semi-permeable cover coupled to the porous substrate;

a first tube coupled adjacent to the porous substrate, the first tube configured to be coupled to a vacuum source;

a second tube coupled adjacent to the porous substrate, the second tube configured to be coupled to a liquid supply source; and

a therapeutic material coupled to and adjacent with a surface of the porous substrate, the therapeutic material being at least one of a silver-impregnated material, a biodegradable material, or a biocompatible material.

2 . The apparatus of claim 1 , wherein the therapeutic material is woven nylon coated with substantially pure metallic silver.

3 . The apparatus of claim 1 , wherein the therapeutic material is polylactide-coglycolic acid (PLGA).

4 . The apparatus of claim 1 , wherein the therapeutic material is an acellular dermal matrix.

5 . The apparatus of claim 1 , wherein the therapeutic material is an autologous

6 . An apparatus, comprising:

a porous substrate;

a semi-permeable cover coupled to the porous substrate;

a therapeutic material bonded to the porous substrate such that the therapeutic material is configured to be released from the porous substrate and remain within a wound when the porous substrate is removed from the wound, the therapeutic material being at least one of a silver-impregnated material, a biodegradable material, or a biocompatible material.

7 . The apparatus of claim 6 , further comprising a first tube coupled adjacent to the porous substrate, the first tube configured to be coupled to a vacuum source.

8 . The apparatus of claim 6 , further comprising a second tube coupled adjacent to the porous substrate, the second tube configured to be coupled to a liquid supply source.

9 . The apparatus of claim 6 , wherein the therapeutic material is woven nylon coated with substantially pure metallic silver.

10 . The apparatus of claim 6 , wherein the therapeutic material is polylactide-coglycolic acid (PLGA).

11 . The apparatus of claim 6 , wherein the therapeutic material is an acellular dermal matrix.

12 . The apparatus of claim 6 , wherein the therapeutic material is an autologous graft.

13 . An apparatus, comprising:

a porous substrate;

a first tube coupled adjacent to the porous substrate;

a second tube coupled adjacent to the porous substrate; and

a therapeutic material bonded to the porous substrate such that the therapeutic material is configured to be released from the porous substrate and remain within a wound when the porous substrate is removed from the wound, the therapeutic material being at least one of a silver-impregnated material, a biodegradable material, or a biocompatible material.

14 . The apparatus of claim 13 , wherein the first tube is configured to be coupled to a vacuum source.

15 . The apparatus of claim 13 , wherein the second tube is configured to be coupled to a liquid supply source.

16 . The apparatus of claim 13 , further comprising a semi-permeable cover coupled to the porous substrate.

17 . The apparatus of claim 13 , wherein the therapeutic material is woven nylon coated with substantially pure metallic silver.

18 . The apparatus of claim 13 , wherein the therapeutic material is polylactide-coglycolic acid (PLGA).

19 . The apparatus of claim 13 , wherein the therapeutic material is an acellular dermal matrix.

20 . The apparatus of claim 13 , wherein the therapeutic material is an autologous graft.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2008
From: VOGEL, RICHARD C.
To: INNOVATIVE THERAPIES, INC.
Reel/Frame 020576/0523 →